Inflammatory Arthritis in Clinical Practice (eBook)
X, 118 Seiten
Springer London (Verlag)
978-1-84628-933-0 (ISBN)
There has been a revolution in treatments for inflammatory arthritis. Mostly, this is due to the introduction of biologics, particularly TNF inhibitors. These have changed approach to treatment in two ways. First, they appear substantially more effective than conventional drugs. Second, they are far more expensive than traditional treatment approaches. One consequence of this therapeutic revolution is a need to better understand arthritis and to place the new biological treatments into the context of existing management approaches.
David L Scott is Professor of Clinical Rheumatology at King's College School of Medicine, London, UK. He also leads the clinical service at King's College Hospital, London. His medical training was in Leeds, and he was introduced to rheumatology by working with Professor Verna Wright. He subsequently spent some years in Birmingham, completing research training for his MD with Professor Kenneth Walton and Professor Paul Bacon. He was an ARC and Wellcome Trust travelling fellow in the US and Europe and subsequently held the Muir Hambro Fellowship of the Royal College of Physicians. His research focuses on the treatment and outcome of arthritis, and he has written over 250 papers and been involved in 25 books in the field. He spent 5 years as editor of Rheumatology and is currently honorary Heberden Librarian at the British Society for Rheumatology. He is involved with many patient groups including Arthritis Care and the Arthritis and Musculoskeletal Alliance. He also serves on the Disability Living Allowance Advisory Board of the Department of Work and Pensions.
There has been a revolution in treatments for inflammatory arthritis. Mostly, this is due to the introduction of biologics, particularly TNF inhibitors. These have changed approach to treatment in two ways. First, they appear substantially more effective than conventional drugs. Second, they are far more expensive than traditional treatment approaches. One consequence of this therapeutic revolution is a need to better understand arthritis and to place the new biological treatments into the context of existing management approaches.
David L Scott is Professor of Clinical Rheumatology at King’s College School of Medicine, London, UK. He also leads the clinical service at King’s College Hospital, London. His medical training was in Leeds, and he was introduced to rheumatology by working with Professor Verna Wright. He subsequently spent some years in Birmingham, completing research training for his MD with Professor Kenneth Walton and Professor Paul Bacon. He was an ARC and Wellcome Trust travelling fellow in the US and Europe and subsequently held the Muir Hambro Fellowship of the Royal College of Physicians. His research focuses on the treatment and outcome of arthritis, and he has written over 250 papers and been involved in 25 books in the field. He spent 5 years as editor of Rheumatology and is currently honorary Heberden Librarian at the British Society for Rheumatology. He is involved with many patient groups including Arthritis Care and the Arthritis and Musculoskeletal Alliance. He also serves on the Disability Living Allowance Advisory Board of the Department of Work and Pensions.
Rheumatoid arthritis.- Spondyloarthropathies.- Symptomatic drug treatment.- Disease-modifying antirheumatic drugs.- Biologics in rheumatoid arthritis.- Systemic and local steroids.- Non-pharmacological therapy.
| Erscheint lt. Verlag | 19.11.2007 |
|---|---|
| Zusatzinfo | X, 118 p. 30 illus. |
| Verlagsort | London |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Allgemeinmedizin |
| Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Orthopädie | |
| Medizin / Pharmazie ► Pflege | |
| Medizin / Pharmazie ► Physiotherapie / Ergotherapie | |
| Schlagworte | Arthritis • Arthropathie • Management • Rehabilitation • rehabilitation psychology • Rehabilitation Therapy • Rheumatoid Arthritis • rheumatology • therapy • Treatment |
| ISBN-10 | 1-84628-933-5 / 1846289335 |
| ISBN-13 | 978-1-84628-933-0 / 9781846289330 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 5,3 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
